Works matching IS 25233548 AND DT 2022 AND VI 42 AND IP 12

Results: 14

Sintilimab versus docetaxel as second‐line treatment in advanced or metastatic squamous non‐small‐cell lung cancer: an open‐label, randomized controlled phase 3 trial (ORIENT‐3).

Published in:

Cancer Communications, 2022, v. 42, n. 12, p. 1314, doi. 10.1002/cac2.12385

By:

Shi, Yuankai;
Wu, Lin;
Yu, Xinmin;
Xing, Puyuan;
Wang, Yan;
Zhou, Jianying;
Wang, Airong;
Shi, Jianhua;
Hu, Yi;
Wang, Ziping;
An, Guangyu;
Fang, Yong;
Sun, Sanyuan;
Zhou, Caicun;
Wang, Changli;
Ye, Feng;
Li, Xingya;
Wang, Junye;
Wang, Mengzhao;
Liu, Yunpeng

Publication type:

Article

Multiplexed imaging of tumor immune microenvironmental markers in locally advanced or metastatic non‐small‐cell lung cancer characterizes the features of response to PD‐1 blockade plus chemotherapy.

Published in:

Cancer Communications, 2022, v. 42, n. 12, p. 1331, doi. 10.1002/cac2.12383

By:

Wu, Fengying;
Jiang, Tao;
Chen, Gongyan;
Huang, Yunchao;
Zhou, Jianying;
Lin, Lizhu;
Feng, Jifeng;
Wang, Zhehai;
Shu, Yongqian;
Shi, Jianhua;
Hu, Yi;
Wang, Qiming;
Cheng, Ying;
Chen, Jianhua;
Lin, Xiaoyan;
Wang, Yongsheng;
Huang, Jianan;
Cui, Jiuwei;
Cao, Lejie;
Liu, Yunpeng

Publication type:

Article

Lymphatic metastasis in non‐small cell lung cancer: recent discoveries and novel therapeutic targets.

Published in:

Cancer Communications, 2022, v. 42, n. 12, p. 1403, doi. 10.1002/cac2.12378

By:

Diao, Xiayao;
Guo, Chao;
Li, Shanqing

Publication type:

Article

Optimized therapeutic strategy for patients with refractory or relapsed acute myeloid leukemia: long‐term clinical outcomes and health‐related quality of life assessment.

Published in:

Cancer Communications, 2022, v. 42, n. 12, p. 1387, doi. 10.1002/cac2.12376

By:

Yan, Chen‐hua;
Wang, Yu;
Sun, Yu‐qian;
Cheng, Yi‐fei;
Mo, Xiao‐dong;
Wang, Feng‐rong;
Chen, Yu‐hong;
Zhang, Yuan‐yuan;
Han, Ting‐ting;
Chen, Huan;
Xu, Lan‐ping;
Zhang, Xiao‐hui;
Liu, Kai‐yan;
Huang, Xiao‐jun

Publication type:

Article

The diagnosis, classification, and treatment of sarcoma in this era of artificial intelligence and immunotherapy.

Published in:

Cancer Communications, 2022, v. 42, n. 12, p. 1288, doi. 10.1002/cac2.12373

By:

Crombé, Amandine;
Roulleau‐Dugage, Mathtieu;
Italiano, Antoine

Publication type:

Article

Genomic characterization reveals distinct mutation landscapes and therapeutic implications in neuroendocrine carcinomas of the gastrointestinal tract.

Published in:

Cancer Communications, 2022, v. 42, n. 12, p. 1367, doi. 10.1002/cac2.12372

By:

Wu, Huanwen;
Yu, Zicheng;
Liu, Yueping;
Guo, Lei;
Teng, Lianghong;
Guo, Lingchuan;
Liang, Li;
Wang, Jing;
Gao, Jie;
Li, Ruiyu;
Yang, Ling;
Nie, Xiu;
Su, Dan;
Liang, Zhiyong

Publication type:

Article

Current updates of CRISPR/Cas9‐mediated genome editing and targeting within tumor cells: an innovative strategy of cancer management.

Published in:

Cancer Communications, 2022, v. 42, n. 12, p. 1257, doi. 10.1002/cac2.12366

By:

Allemailem, Khaled S.;
Alsahli, Mohammed A;
Almatroudi, Ahmad;
Alrumaihi, Faris;
Alkhaleefah, Fahd Khaleefah;
Rahmani, Arshad Husain;
Khan, Amjad Ali

Publication type:

Article

N‐acetyltransferase 10 promotes colon cancer progression by inhibiting ferroptosis through N4‐acetylation and stabilization of ferroptosis suppressor protein 1 (FSP1) mRNA.

Published in:

Cancer Communications, 2022, v. 42, n. 12, p. 1347, doi. 10.1002/cac2.12363

By:

Zheng, Xiao;
Wang, Qi;
Zhou, You;
Zhang, Dachuan;
Geng, Yiting;
Hu, Wenwei;
Wu, Changping;
Shi, Yufang;
Jiang, Jingting

Publication type:

Article

Lipid metabolism in pancreatic cancer: emerging roles and potential targets.

Published in:

Cancer Communications, 2022, v. 42, n. 12, p. 1234, doi. 10.1002/cac2.12360

By:

Yin, Xinpeng;
Xu, Ruiyuan;
Song, Jianlu;
Ruze, Rexiati;
Chen, Yuan;
Wang, Chengcheng;
Xu, Qiang

Publication type:

Article

Smoking, smoking cessation, and survival after cancer diagnosis in 128,423 patients across cancer types.

Published in:

Cancer Communications, 2022, v. 42, n. 12, p. 1421, doi. 10.1002/cac2.12357

By:

Tu, Huakang;
Ye, Yuanqing;
Huang, Maosheng;
Xie, Kunlin;
Chow, Wong‐Ho;
Zhao, Hua;
Wu, Xifeng

Publication type:

Article

Evaluation of immune response to anti‐COVID‐19 booster in cancer patients and chronic medical cannabis users and its association with circulating Eosinophils levels.

Published in:

Cancer Communications, 2022, v. 42, n. 12, p. 1417, doi. 10.1002/cac2.12353

By:

Idan, Cohen;
Salvatore, Campisi‐Pinto;
Orit, Rozenberg;
Ariel, Abaev;
Marah, Khoury;
Dana, Agbaria;
Harel, Eitam;
Raul, Colodner;
Mona, Khoury;
Hassan, Shalabna;
Yousef, Samih;
Camel, Mahamid;
Mahmoud, Abu‐Amna;
Gil, Bar‐Sela

Publication type:

Article

miR‐99a‐5p modulates doxorubicin resistance via the COX‐2/ABCG2 axis in triple‐negative breast cancer: from the discovery to in vivo studies.

Published in:

Cancer Communications, 2022, v. 42, n. 12, p. 1412, doi. 10.1002/cac2.12352

By:

Garrido‐Cano, Iris;
Adam‐Artigues, Anna;
Lameirinhas, Ana;
Blandez, Juan F.;
Candela‐Noguera, Vicente;
Rojo, Federico;
Zazo, Sandra;
Madoz‐Gúrpide, Juan;
Lluch, Ana;
Bermejo, Begoña;
Sancenón, Felix;
Cejalvo, Juan Miguel;
Martínez‐Máñez, Ramón;
Eroles, Pilar

Publication type:

Article

Radioimmunotherapy‐induced intratumoral changes in cervical squamous cell carcinoma at single‐cell resolution.

Published in:

Cancer Communications, 2022, v. 42, n. 12, p. 1407, doi. 10.1002/cac2.12342

By:

Liu, Chao;
Yu, Hao;
Huang, Rui;
Lei, Tianyu;
Li, Xiaohui;
Liu, Ming;
Huang, Qingyu;
Du, Qilian;
Xing, Ligang;
Yu, Jinming

Publication type:

Article

Issue Information.

Published in:: Cancer Communications, 2022, v. 42, n. 12, p. 1231, doi. 10.1002/cac2.12176
Publication type:: Article